On March 18, the Shanghai index rose 1.12%, the Shenzhen Component Index rose 0.31% and the gem index rose 0.11%. According to the data of the after hours dragon tiger list, a total of 43 stocks were listed on the Dragon Tiger list due to changes on the same day, and the largest net capital inflow was Staidson(Beijing) Biopharmaceuticals Co.Ltd(300204) ( Staidson(Beijing) Biopharmaceuticals Co.Ltd(300204) . SZ), amounting to 99 million yuan.
According to intelligent monitoring, there are institutions on the list of 16 stocks, and 5 stocks are involved in the list of north-east funds.
99 million funds were raised Staidson(Beijing) Biopharmaceuticals Co.Ltd(300204) , and 97 million funds fled Lanzhou bank
Among the 43 dragon and tiger stocks on the list, 20 stocks were net bought and 23 stocks were net sold. Among them, Staidson(Beijing) Biopharmaceuticals Co.Ltd(300204) is the largest net purchase of funds, with an amount of 99 million yuan, accounting for 4.18% of the total transaction amount Staidson(Beijing) Biopharmaceuticals Co.Ltd(300204) closed up 19.99% on the same day, with a turnover rate of 19.5%.
Today, the biotechnology sector as a whole rose by 2.62%, of which Staidson(Beijing) Biopharmaceuticals Co.Ltd(300204) led the rise by 19.99%.
Staidson(Beijing) Biopharmaceuticals Co.Ltd(300204) latest announcement: the company recently obtained the drug production license issued by Beijing Municipal Drug Administration and agreed to the application for change of drug production license. After the change, the production address and production scope were added, and the classification code was added BH The company obtained the changed drug production license this time, which is conducive to enriching the company’s product layout and optimizing the company’s production capacity.
The largest net outflow of funds in the dragon and tiger list is Bank of Lanzhou (001227. SZ), with a net sales of 97 million yuan, accounting for 5.61% of the total transaction amount. Bank of Lanzhou closed up 4.82% with a turnover rate of 50.32%.
Institutions bought 3 shares and sold 13 shares
On March 18, 16 individual stocks appeared on the Dragon Tiger list, with a total net sales of 258 million yuan. Specifically, institutions bought 3 shares and sold 13 shares
Among them, Shanghai Labway Clinical Laboratory Co.Ltd(301060) ( Shanghai Labway Clinical Laboratory Co.Ltd(301060) . SZ) was the largest net purchase amount of institutions, and closed down 2.87% on the same day, with a turnover rate of 39.51%.
Among the stocks sold by institutions, the Bank of Lanzhou (001227. SZ) had the largest amount. On that day, the closing price rose by 4.82% and the turnover rate was 50.32%.
Northbound capital net bought 2 shares and sold 3 shares
On March 18, BEIXIANG capital participated in a total of five stocks in the dragon and tiger list, with a total net sales of 957871 million yuan of which, Shanghai Stock connect net bought 1 share, with an amount of 2.764 million yuan; Shenzhen Stock connect net bought 1 share and sold 3 shares, with a total net sales of 985511 million yuan.
the largest net purchase amount of northbound funds is Xinjiang Communications Construction Group Co.Ltd(002941) ( Xinjiang Communications Construction Group Co.Ltd(002941) . SZ), net purchase amount is 223733 million yuan, accounting for 1.9% of the total transaction amount The largest amount of net sales was Hyunion Holding Co.Ltd(002537) ( Hyunion Holding Co.Ltd(002537) . SZ), was 658983 million yuan, accounting for 1.86% of the total turnover. The closing price of the day rose 10.04% and the turnover rate was 26.03%.
It is worth noting that institutions and BEIXIANG capital have differences on Xinjiang Communications Construction Group Co.Ltd(002941) , Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) and institutions have net sales of Xinjiang Communications Construction Group Co.Ltd(002941) and BEIXIANG capital has net purchases of 223733 million yuan; Net purchases of Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) 28936800 yuan by institutions and net sales of 21115900 yuan by northbound funds.
(statement: the contents of the article are for reference only and do not constitute investment suggestions. Investors operate accordingly at their own risk.)
